TenX Keane Acquisition announced that it has raised $200,000 in a debt round of funding from new lender Citius Pharmaceuticals, Inc. on January 17, 2024. The company has issued Non Convertible Zero Coupon Promissory Note in the transaction. The note bears no interest and is repayable in full per the terms of the Merger Agreement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.37 USD | +0.09% | +0.35% | +3.93% |
05-17 | TenX Keane Acquisition announced that it has received $0.066667 million in funding | CI |
04-16 | TenX Keane Acquisition Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
- Stock Market
- Equities
- TENK Stock
- News TenX Keane Acquisition
- TenX Keane Acquisition announced that it has received $0.2 million in funding